ArticleACS medicinal chemistry letters2026

Ligand-Engineered Cu(II) Complexes Suppress Stemness and Drug Resistance in Triple-Negative Breast Cancer.

Vemavarapu Durga Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.